Skip to main content

US ClosedU.S. Closed

ANRO: Alto Neuroscience, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications.

52W Range

93rdpctl

Volume

0.53×avg

Market Cap

1.23BUSD

P/E Ratio

-14.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Alto Neuroscience, Inc.

ANRONew York Stock Exchange·USD·Closed

Alto Neuroscience, Inc.

ANRONew York Stock Exchange·USD·Closed

$35.13

−3.22%

$35.13

−$1.17 (3.22%)

52W Range

93rdpctl

Volume

0.53×avg

Mkt Cap

1.23BUSD

P/E

-14.2TTM

Div Yield

–ann